Zyga gets $10M boost, expects CE mark for Glyder device by year's end

12/17/2013 | Medical Device & Diagnostic Industry online

A funding round has pulled in $10 million for Zyga Technology, maker of the FDA-cleared SImmetry Sacroiliac Joint Fusion System designed to treat hip and lower back pain. The company also hopes to obtain CE mark approval in Europe for its Glyder Facet Resurfacing System, which is used to treat chronic facetogenic pain, by the close of the year.

View Full Article in:

Medical Device & Diagnostic Industry online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT